About Redbud Labs
Redbud Labs is a company based in Chapel Hill (United States) founded in 2010. Redbud Labs has raised $305 thousand across 14 funding rounds from investors including HHS, VentureSouth and America’s Seed Fund. The company has 20 employees as of December 31, 2024. Redbud Labs offers products and services including Redbud NA1, MXR, and STR. Redbud Labs operates in a competitive market with competitors including Lunaphore, Mekonos, Parallel Fluidics, CellFE and Lightcast Discovery, among others.
- Headquarter Chapel Hill, United States
- Employees 20 as on 31 Dec, 2024
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Redbuds Labs, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$305 K (USD)
in 14 rounds
-
Latest Funding Round
$3.34 M (USD), Grant
Jun 01, 2022
-
Investors
HHS
& 2 more
-
Employee Count
20
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Redbud Labs
Redbud Labs offers a comprehensive portfolio of products and services, including Redbud NA1, MXR, and STR.
Automated system for reliable pathogen extractions in labs
Magnetic micro-posts for efficient microfluidic mixing applications
Technology for cell stirring in molecular processes
Funding Insights of Redbud Labs
Redbud Labs has successfully raised a total of $305K across 14 strategic funding rounds. The most recent funding activity was a Grant round of $3.34 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $3.3M
-
First Round
First Round
(01 Jun 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Grant - Redbud Labs | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Redbud Labs | Valuation |
investors |
|
| Jun, 2021 | Amount | Series A - Redbud Labs | Valuation | VentureSouth |
|
Investors in Redbud Labs
Redbud Labs has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, VentureSouth and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage ventures in the Southeast are supported by VentureSouth.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Redbud Labs
Financial Statements - Redbud Labs
Redbud Labs Comparisons
Competitors of Redbud Labs
Redbud Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lunaphore, Mekonos, Parallel Fluidics, CellFE and Lightcast Discovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microfluidic-based instruments for tumor analysis are developed.
|
|
| domain | founded_year | HQ Location |
Silicon-based nanomachine chips are developed for cell engineering applications.
|
|
| domain | founded_year | HQ Location |
Microfluidic chips are provided for research labs using embossing technology.
|
|
| domain | founded_year | HQ Location |
Intracellular gene delivery platform is developed using microfluidic devices.
|
|
| domain | founded_year | HQ Location |
Advanced single-cell analysis solutions are provided for biotechnology research.
|
|
| domain | founded_year | HQ Location |
Cell therapy solutions for multiple therapeutic areas are developed.
|
Frequently Asked Questions about Redbud Labs
Redbud Labs was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Redbud Labs is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
Redbud Labs is a funded company, having raised a total of $305K across 14 funding rounds to date. The company's 1st funding round was a Grant of $1.29M, raised on Jun 01, 2012.
As of Dec 31, 2024, the latest employee count at Redbud Labs is 20.
Redbud Labs was founded in 2010 and is based in Chapel Hill, United States. Microfluidic platforms are produced for biosensing and sample processing within the biotechnology sector. Actuated surface-attached posts (ASAPs) are employed in these platforms, consisting of micro-posts that bend under magnetic fields to handle fluids, cells, and reagents. Operations focus on life science research tools and clinical diagnostics development, with applications in fluid manipulation at sub-bacterial scales.
Redbud Labs's top competitors include CellFE, Parallel Fluidics and Lightcast Discovery.
Redbud Labs offers Redbud NA1, MXR, and STR.
Redbud Labs has 3 investors. Key investors include HHS, VentureSouth, and America’s Seed Fund.